2020 Innovating Decisions and Empowering Action (IDEA) in Diabetes Management 2.0

The overall goal of IDEA (Innovating Decisions and Empowering Action in Diabetes Management) is to improve understanding of continuous glucose monitoring (CGM), report interpretations, and the use of this information to optimize therapeutic management leading to practice transformation and increased shared decision-making. Substantial evidence exists to support the safety and efficacy of CGM in adult and pediatric populations. Though challenges to adoption and use remain, newer generations of CGM with improved accuracy, factory calibration, and fingerstick replacement are decreasing burdens and improving efficacy. Guidelines for CGM use are progressing to recommend its use across the spectrum of people with diabetes. The IDEA Project is a major educational initiative that will change the way CGM data is interpreted and used in diabetes care by health care professionals and by patients with diabetes.

Learning Objectives


At the conclusion of this activity, participants should be able to:
  • Identify current guidelines for utilization of CGM in the care of patients with diabetes
  • Compare and contrast current CGM guideline recommendations
  • Anticipate common questions from patients and clinicians related to CGM
  • Discuss current and emerging advances in the use of CGM

Acknowledgement of Commercial Support


This activity is supported by an educational grants from Abbott Diabetes Care, AstraZeneca, Eli Lilly, Medtronic, and Novo Nordisk Inc.